Table 1 Demographic, clinical characteristics, and pharmacological treatment at baseline (n = 11)
From: Structured physical exercise for bipolar depression: an open-label, proof-of concept study
Characteristics of sample (Baseline) | |
|---|---|
Female (n) | 8 |
Age (years) – mean ± SD (range) | 42 ± 9 (29–55) |
Body weight (kg) – mean ± SD (range) | 72 ± 14 (51–97) |
BMI (kg/m2) – mean ± SD (range) | 26 ± 4 (21–32) |
MADRS Score (points) – mean ± SD (range) | 23.6 ± 8.3 (14–40) |
YMRS Score (points) – mean ± SD (range) | 2.7 ± 3.3 (0–10) |
VO2peak (mL/kg/min− 1) – mean ± SD (range) | 25 ± 7 (16–43) |
Muscle strength (kg) – mean ± SD (range) | 42 ± 10 (25–55) |
Body fat percentage (%) – mean ± SD (range) | 31 ± 8 (14–44) |
Employed or student (n) | 4 |
Unemployed (n) | 7 |
Married (n) | 3 |
Smoking (n) | 1 |
Bipolar Disorder Subtype and polarity of first episode | |
Type 1 (n) | 6 |
Type 2 (n) | 5 |
Polarity of first episode – Depression (n) | 10 |
Polarity of First episode – Mania (n) | 1 |
Stable pharmacotherapies at baseline (by class) | |
Antidepressants | |
Any antidepressant agent (n) | 5 |
Mood stabilizers and atypical antipsychotics | |
Lithium (n) | 5 |
Lamotrigine (n) | 2 |
Quetiapine (n) | 6 |
Olanzapine (n) | 1 |
Carbamazepine (n) | 1 |
Other treatments | |
Benzodiazepines (n) | 6 |
Topiramate (n) | 3 |
Haloperidol (n) | 1 |